201 related articles for article (PubMed ID: 34956559)
1. MiR-29c-3p May Promote the Progression of Alzheimer's Disease through BACE1.
Cao Y; Tan X; Lu Q; Huang K; Tang X; He Z
J Healthc Eng; 2021; 2021():2031407. PubMed ID: 34956559
[TBL] [Abstract][Full Text] [Related]
2. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
Wang X; Li M; Hu Y
Physiol Res; 2023 Dec; 72(6):833-841. PubMed ID: 38215068
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway.
Sha S; Shen X; Cao Y; Qu L
Aging (Albany NY); 2021 Jun; 13(11):15285-15306. PubMed ID: 34086603
[TBL] [Abstract][Full Text] [Related]
4. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y
Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
[TBL] [Abstract][Full Text] [Related]
6. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.
Zhu HC; Wang LM; Wang M; Song B; Tan S; Teng JF; Duan DX
Brain Res Bull; 2012 Sep; 88(6):596-601. PubMed ID: 22721728
[TBL] [Abstract][Full Text] [Related]
8. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
He L; Chen Z; Wang J; Feng H
BMC Neurol; 2022 Jun; 22(1):203. PubMed ID: 35659599
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
Long JM; Ray B; Lahiri DK
J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
[TBL] [Abstract][Full Text] [Related]
10. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
11. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.
Zhang J; Hu M; Teng Z; Tang YP; Chen C
J Neurosci; 2014 Nov; 34(45):14919-33. PubMed ID: 25378159
[TBL] [Abstract][Full Text] [Related]
12. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
[TBL] [Abstract][Full Text] [Related]
14. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
15. miR-186 is decreased in aged brain and suppresses BACE1 expression.
Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
[TBL] [Abstract][Full Text] [Related]
16. LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
Zhou Y; Ge Y; Liu Q; Li YX; Chao X; Guan JJ; Diwu YC; Zhang Q
Neuroscience; 2021 Feb; 455():52-64. PubMed ID: 33197504
[TBL] [Abstract][Full Text] [Related]
17. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
18. miR-212-3p attenuates neuroinflammation of rats with Alzheimer's disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway.
Nong W; Bao C; Chen Y; Wei Z
Bosn J Basic Med Sci; 2022 Jul; 22(4):540-552. PubMed ID: 35150479
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation
Wang L; Liu J; Wang Q; Jiang H; Zeng L; Li Z; Liu R
Front Pharmacol; 2019; 10():806. PubMed ID: 31379578
[TBL] [Abstract][Full Text] [Related]
20. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
Ji Y; Wang D; Zhang B; Lu H
J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
